Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
50,231,941
-
Shares change
-
+4,238,271
-
Total reported value, excl. options
-
$302,897,871
-
Value change
-
+$25,616,806
-
Put/Call ratio
-
77%
-
Number of buys
-
37
-
Number of sells
-
-10
-
Price
-
$6.03
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q1 2023
64 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q1 2023.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,231,941 shares
of 55,351,475 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (29,225,579 shares), FMR LLC (5,417,659 shares), HarbourVest Partners LLC (3,512,110 shares), Artal Group S.A. (2,533,045 shares), STATE OF WISCONSIN INVESTMENT BOARD (1,857,265 shares), VANGUARD GROUP INC (1,398,920 shares), CHI Advisors LLC (1,055,882 shares), PLATINUM INVESTMENT MANAGEMENT LTD (923,291 shares), Laurion Capital Management LP (571,108 shares), and BlackRock Inc. (547,074 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.